Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2006.09.4565PMID 17577038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

  2006cited by this paper
• Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.

  2006cited by this paper
• Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.

  2006cited by this paper
• Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node Metastases

  2006cited by this paper
• Dendritic cell infiltration and prognosis of human hepatocellular carcinoma

  2006cited by this paper
• Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

  2006cited by this paper
• Tumor-Infiltrating Cytotoxic T Cells but not Regulatory T Cells Predict Outcome in Anal Squamous Cell Carcinoma

  2006cited by this paper
• Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites

  2006cited by this paper
• Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.

  2006cited by this paper
• Regulatory T cells, tumour immunity and immunotherapy

  2006cited by this paper
• Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

  2006cited by this paper
• Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

  2006cited by this paper
• Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.

  2006cited by this paper
• Tumor-infiltrating T lymphocytes: friends or foes?

  2006cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005cited by this paper
• Tumor-infiltrating T cells--friend or foe of neoplastic cells?

  2005cited by this paper
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

  2005cited by this paper
• Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

  2005cited by this paper
• Current concepts of tumor-infiltrating lymphocytes in human malignancies.

  2005cited by this paper
• A molecular view of cytotoxic T lymphocyte induced killing.

  2005cited by this paper
• Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T‐regulatory cells

  2005cited by this paper
• Updated treatment approach to hepatocellular carcinoma

  2005cited by this paper
• Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

  2005cited by this paper
• Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells

  2005cited by this paper
• A decade’s studies on metastasis of hepatocellular carcinoma

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal disease

  2003cited by this paper
• Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.

  2002cited by this paper
• Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.

  2001cited by this paper
• Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.

  2001cited by this paper
• CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis

  2001cited by this paper
• Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration

  1998cited by this paper

• Dietary intervention reshapes gut microbiota and lipid metabolism to enhance anti-tumor immunity and prognosis in hepatocellular carcinoma: a randomized controlled trial

  2026cites this paper
• Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy

  2026cites this paper
• Enhancing cDC1-mediated anti-tumor immunity limits tumor progression and potentiates anti-PD-1 therapy in intrahepatic cholangiocarcinoma

  2025cites this paper
• Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma

  2025cites this paper
• A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer

  2025cites this paper
• Predicting the prognosis of radical gastrectomy for patients with locally advanced gastric cancer after neoadjuvant chemotherapy using machine learning technology: a multicenter study in China

  2025cites this paper
• The role of interleukin-17 in inflammation-related cancers

  2025cites this paper
• Impact of HTLV-1 infection on clinicopathological characteristics and tumour immune microenvironment in colorectal cancer

  2025cites this paper
• Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC

  2025cites this paper
• CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment

  2025cites this paper
• Predictive value of neutrophil to lymphocyte ratio for the clinical outcomes of acquired immune deficiency syndrome: a systematic review and meta-analysis

  2025cites this paper
• Novel immune-related prognostic models for patients with hepatocellular carcinoma after curative resection

  2025cites this paper
• The Predictive Significance of Interleukin-2 Receptor in Patients with Hepatocellular Carcinoma

  2025cites this paper
• Safety and toxicity risks of radiotherapy combined with PD-1/PD-L1 inhibitors: A comprehensive review

  2025cites this paper
• Morphofunctional changes in the immune system in colitis-associated colorectal cancer in tolerant and susceptible to hypoxia mice

  2025cites this paper
• T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells

  2025cites this paper
• Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma

  2025cites this paper
• PD1+ Treg cell remodeling promotes immune homeostasis within peripheral blood and tumor microenvironment after microparticles-transarterial chemoembolization in hepatocellular carcinoma

  2025cites this paper
• Immunoscore CD3/CD8 and FOXP3 Expression Correlate to Neoadjuvant Chemotherapy Response in Triple Negative Breast Cancer: A Case-Control Study

  2025cites this paper
• Matrix Stiffness Promotes Invasion and Metastasis of Hepatocellular Carcinoma via a New Mechanoresponsive SCD1/HMMR Pathway

  2025cites this paper
• Hepatocellular Carcinoma – from Immunobiology to Immunotherapy

  2025cites this paper
• Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients

  2025cites this paper
• Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma

  2025cites this paper
• Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma

  2025cites this paper
• Immunometabolism of regulatory T cells in cancer

  2025cites this paper
• Regulatory T cells in the tumour microenvironment

  2025cites this paper
• Role of Alpha-Fetoprotein in the Pathogenesis of Cancer.

  2024cites this paper
• Remaining Issues Related to Serum Cytokines in Patients with Unresectable Hepatocellular Carcinoma Treated by Atezolizumab plus Bevacizumab Combination Treatment

  2024cites this paper
• Endothelial cells in tumor microenvironment: insights and perspectives

  2024cites this paper
• Regulatory T cell: A promising therapeutic target in tumor microenvironment.

  2024cites this paper
• Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.

  2024cites this paper
• Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies

  2024cites this paper
• The Usefulness of Serum Interleukin-6 as a Predictor of Response to Atezolizumab plus Bevacizumab Combination Treatment in Hepatocellular Carcinoma

  2024influential citation
• Exosomal PDL1 Suppresses the Anticancer Activity of CD8+ T Cells in Hepatocellular Carcinoma

  2024cites this paper
• Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment

  2024cites this paper
• IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

  2024cites this paper
• Immune regulation and therapeutic application of T regulatory cells in liver diseases

  2024cites this paper
• Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis

  2024cites this paper
• Heterogenous liver parenchymal enhancement in CT is a favorable prognosis of HCC after hepatic resection.

  2024cites this paper
• Radio-Immunomics in Hepatocellular Carcinoma: Unraveling the Tumor Immune Microenvironment

  2024cites this paper
• Identification and Validation of Basement Membrane Related LncRNA Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma

  2024cites this paper
• Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study

  2024cites this paper
• Immunotherapy for hepatocellular carcinoma

  2024cites this paper
• Immunotherapy for hepatocellular carcinoma

  2024cites this paper
• Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development

  2024cites this paper
• Cholesterol and Immune Microenvironment: Path Towards Tumorigenesis

  2024cites this paper
• A Multicenter International Retrospective Investigation Assessing the Prognostic Role of Inflammation-Based Scores (Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC) Undergoing Chemoembolizations of

  2024cites this paper
• TRIP13: A promising cancer immunotherapy target

  2024cites this paper
• Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma

  2024cites this paper
• Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies

  2024cites this paper
• Prognostic relevance of sarcopenia and tumor‐infiltrating CD8 + T cells in patients with hepatocellular carcinoma

  2024cites this paper
• Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts.

  2024cites this paper
• Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication

  2024cites this paper
• Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis

  2024cites this paper
• Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives

  2024cites this paper
• Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response

  2024cites this paper
• Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma

  2024cites this paper
• The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance

  2024cites this paper
• YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53

  2024cites this paper
• Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures

  2024cites this paper
• Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances

  2024cites this paper
• Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy

  2024cites this paper
• A new target of radiotherapy combined with immunotherapy: regulatory T cells

  2024cites this paper
• KIF4A functions as a diagnostic and prognostic biomarker and regulates tumor immune microenvironment in skin cutaneous melanoma.

  2024cites this paper
• Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer

  2024cites this paper
• Construction of a prognostic prediction model in liver cancer based on genes involved in integrin cell surface interactions pathway by multi-omics screening

  2024cites this paper
• Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

  2024cites this paper
• Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma

  2023cites this paper
• Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study

  2023cites this paper
• The Peritumoral CD8+/FOXP3+ Cell Ratio Has Prognostic Value in Triple-negative Breast Cancer

  2023cites this paper
• SONAR enables cell type deconvolution with spatially weighted Poisson-Gamma model for spatial transcriptomics

  2023cites this paper
• Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer

  2023cites this paper
• Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma

  2023cites this paper
• An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma

  2023cites this paper
• Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway

  2023cites this paper
• New techniques: a roadmap for the development of HCC immunotherapy

  2023cites this paper
• Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma

  2023cites this paper
• In vivo transfection of cytokine genes into tumor cells using a synthetic vehicle promotes antitumor immune responses in a visceral tumor model

  2023cites this paper
• The Research Progress of Traditional Chinese Medicine in the Treatment of Liver Cancer Based on the Microenvironment

  2023cites this paper
• Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization

  2023cites this paper
• Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma

  2023cites this paper
• Mechanism of inert inflammation in an immune checkpoint blockade-resistant tumor subtype bearing transcription elongation defects.

  2023cites this paper
• Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3 cm without Vascular Invasion: A Propensity-Score Matched Survival Analysis.

  2023cites this paper
• The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma

  2023cites this paper
• Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors

  2023influential citation
• Spatial immunophenotypes predict clinical outcome in intrahepatic cholangiocarcinoma.

  2023cites this paper
• Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy.

  2023cites this paper
• DNA hypomethylation mediates immune response in pan-cancer

  2023cites this paper
• RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker

  2023cites this paper
• Clinical significance of FOXP3 mRNA expression in patients with B chronic lymphocytic leukemia: A preliminary study.

  2023cites this paper
• Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma

  2023cites this paper
• Tumor cell density dependent IL-8 secretion induces the fluctuation of tregs/CD8 + T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint

  2023cites this paper
• Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma

  2023cites this paper
• Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial

  2023cites this paper
• Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy

  2023cites this paper
• Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date.

  2023cites this paper
• Prognostic biomarkers in and selection of surgical patients with hepatocellular carcinoma

  2023cites this paper
• Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma

  2023cites this paper
• Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer

  2023cites this paper
• The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression

  2023cites this paper